North Dakota

Overview

North Dakota legalized medical cannabis via Measure 5 of November 8, 2016 (63.7% approval), codified at North Dakota Century Code Chapter 19-24.1. Implementation legislation in 2017 modified several voter-approved provisions (notably removing home cultivation and adding a list of qualifying conditions). Licensed medical dispensary sales began in 2019.

Adult-use cannabis remains illegal. Measure 3 of 2018 and Measure 2 of 2022 both proposed adult-use legalization at the ballot and both failed. Possession of small amounts of cannabis is decriminalized: under NDCC §19-03.1-23.1, possession of 0.5 ounce (14 grams) or less is an infraction with no jail time and a fine; this is distinct from full adult-use legalization.

The North Dakota Department of Health and Human Services (DHHS) administers the medical-marijuana program.

Adult-use status

Adult-use cannabis is illegal. Possession of 0.5 ounce or less is an infraction; possession of larger amounts scales to misdemeanor or felony under NDCC Chapter 19-03.1, with felony penalties for substantial quantities, distribution, or repeat offenses.

Medical program (Measure 5, 2016)

Qualifying conditions

North Dakota's medical-cannabis program enumerates qualifying conditions including:

• Cancer, glaucoma, HIV/AIDS
• ALS, multiple sclerosis, Parkinson's disease, Alzheimer's disease
• Crohn's disease
• Severe and chronic pain, severe nausea
• Cachexia / wasting
• Seizure disorders, epilepsy
• Post-traumatic stress disorder
• Autism spectrum disorder (added by rulemaking)
• Terminal illness

Patient access

• Possession: up to 3 ounces of usable cannabis over any 30-day period under medical registration.
• Home cultivation: prohibited (the original voter measure permitted limited cultivation; the 2017 implementation legislation removed this).
• Reciprocity: none. Patients must be North Dakota residents to register.
• Approved forms: flower, edibles, oils, tinctures, capsules, vapes, topicals.

Patients and caregivers

• Patient minimum age: 19 (matching North Dakota's general age-of-majority for these purposes). Minor patients require parent/legal guardian as designated caregiver plus physician certification.
• Caregiver minimum age: 21.
• Caregivers per patient: up to 1 designated caregiver per patient.
• Caregiver registration: via DHHS; criminal background check.

Patient registration steps

1. Obtain a written certification from a North Dakota-licensed physician, physician assistant, or advanced practice registered nurse who is willing to certify a qualifying condition through a bona fide patient-provider relationship.
2. The provider submits the certification through the DHHS Medical Marijuana Program portal.
3. The patient applies online through the DHHS portal, submits identity documents and a current photo, and pays the registration fee. Reduced fees apply for veterans, Medicaid recipients, and patients with limited household income.
4. Once approved, the patient receives a state-issued medical-marijuana ID card valid for one year. The card authorizes purchases at any licensed North Dakota dispensary.

Minor patients require a parent or legal guardian as designated caregiver and a written statement from a second physician confirming the certification. The caregiver completes a separate application and background check.

Reciprocity and visiting patients

North Dakota does not extend reciprocity to any out-of-state medical-cannabis program. Patients must be North Dakota residents to register. Visiting patients carrying medical cards from Minnesota, Montana, or South Dakota cannot purchase from North Dakota dispensaries and remain subject to state criminal penalties for any cannabis brought across the border.

The 0.5 oz infraction-only threshold provides some practical protection for visiting patients carrying small amounts. It does not eliminate criminal-record exposure for amounts over the threshold or for any sale or distribution activity.

Employment and workplace

North Dakota provides limited statutory protection for registered medical-cannabis patients. Employers may not discriminate against an employee solely on the basis of registry status, but the protection has the standard carve-outs:

• Safety-sensitive positions: employers may continue to enforce drug-free workplace policies for safety-sensitive roles as defined by the employer.
• Federal contractor and DOT-regulated positions: federal drug-free workplace and DOT testing rules supersede state-level patient protection.
• Post-accident testing: workers' compensation benefits may be denied where post-incident testing returns positive for THC without contemporaneous documentation of medical use within the patient's certified parameters.

Public-employee positions, healthcare licensing, and CDL holders face additional licensing-board exposure beyond employer discipline.

Failed adult-use ballot history

North Dakota voters have considered adult-use legalization twice since 2018:

• 2018 (Measure 3): failed with roughly 41% support. The measure proposed broad legalization without an extensive regulatory framework.
• 2022 (Measure 2): failed with roughly 45% support. The measure proposed a more structured adult-use framework.

The pattern resembles South Dakota's failed adult-use measures. Voter support for medical cannabis (63.7% in 2016) has not translated to adult-use majorities. Activist groups have continued petition-drive efforts; no measure has been certified for the 2026 ballot as of mid-year.

Hemp and CBD legality

North Dakota aligns with the 2018 Federal Farm Bill on industrial hemp (cannabis with 0.3% delta-9 THC by dry weight). The state's hemp program operates under N.D. Cent. Code § 4.1-18.1, administered by the North Dakota Department of Agriculture.

North Dakota is one of the most restrictive states in the United States for intoxicating hemp-derived cannabinoids. HB 1370 of 2023 (signed by Governor Doug Burgum) classified delta-8 THC, delta-10 THC, THC-O, HHC, and similar synthetic or chemically-converted cannabinoids as controlled substances effective August 2023. These products may not lawfully be sold at retail in North Dakota.

Industrial-hemp CBD products and other non-intoxicating hemp items remain legal at general retail under the state Hemp Program, subject to labeling and registration. Smokable hemp flower at retail is restricted under the same total-THC framework. The North Dakota Bureau of Criminal Investigation and the Department of Agriculture have coordinated compliance advisories and enforcement actions against retailers who continued selling banned isomers after the August 2023 effective date.

North Dakota's posture contrasts sharply with neighboring Montana and Minnesota, both of which authorize broader hemp-derived cannabinoid retail under regulated frameworks. Out-of-state visitors carrying intoxicating-hemp products purchased lawfully elsewhere face the same controlled-substance exposure as visitors carrying marijuana. Informational only — not legal advice.

Tribal jurisdiction

North Dakota includes five federally recognized tribal nations. Tribal cannabis policy varies by nation and is independent of state law. Tribal land jurisdiction is distinct from state jurisdiction, and product transported off the reservation onto state or federal land is subject to the applicable non-tribal law.

Federal context

Federal jurisdiction layers additional exposure on federal land, federal courthouses, military installations (Grand Forks Air Force Base, Minot Air Force Base), and interstate highways. Theodore Roosevelt National Park and BLM-administered land fall under federal cannabis prohibition regardless of state medical authorization. I-29 and I-94 corridors see active state-patrol and federal drug-interdiction activity, particularly at the Canadian border (where US Customs and Border Protection enforces federal prohibition).